The interferon-inducible RNA-specific adenosine deaminase (ADAR1) is an RNA editing enzyme implicated in the site-selective deamination of adenosine to inosine in cellular pre-mRNAs. The pre-mRNA for the rat serotonin-2C receptor (5-HT 2C R) possesses four editing sites (A, B, C, and D), which undergo A-to-I nucleotide conversions that alter the signaling function of the encoded G-protein-coupled receptor. Measurements of 5-HT 2C R pre-mRNA editing in vitro revealed site-specific deamination catalyzed by ADAR1. Three splice site variants, ADAR1-a, -b, and -c, all efficiently edited the A site of 5-HT 2C R pre-mRNA, but the D site did not serve as an efficient substrate for any of the ADAR1 variants. Mutational analysis of the three double-stranded (ds) RNA binding motifs present in ADAR1 revealed a different relative importance of the individual dsRNA binding motifs for deamination of the A site of 5-HT 2C R and synthetic dsRNA substrates. Quantitative reverse transcription-polymerase chain reaction analyses demonstrated that the 5-HT 2C R pre-mRNA was most highly expressed in the choroid plexus of rat brain. However, ADAR1 and the related deaminase ADAR2 showed significant expression in all regions of the brain examined, including cortex, hippocampus, olfactory bulb, and striatum, where the 5-HT 2C R pre-mRNA was extensively edited.
RNA editing is a post-transcriptional process by which RNA transcripts are covalently modified in a manner that potentially alters the function of the encoded product (1, 2) . Siteselective conversion of adenosine to inosine represents one such editing process, catalyzed by RNA-specific adenosine deaminases (ADAR) 1 (3) . The ADAR editing enzymes catalyze the C-6 deamination of adenosine in double-stranded (ds) RNA substrates (4, 5) . Following the discovery of ADAR as an RNA unwinding activity (6, 7) , the search for naturally occurring substrates revealed multiple candidate RNAs that defined two types of A-to-I editing processes. First, in viral RNAs such modifications characteristic of adenosine deamination were found at multiple sites, as exemplified by the extensive adenosine modifications present on the viral antisense RNA late in polyoma virus infection (8) and by the biased hypermutations observed in negative-stranded RNA virus genomes during lytic and persistent infections, as in the case of measles virus (9, 10) . Second, highly site-specific A-to-I modifications have also been characterized that occur at one or a few sites in certain viral and cellular RNA transcripts, as demonstrated by the editing of hepatitis delta virus RNA (11) (12) (13) and pre-mRNAs encoding GluR glutamate receptor channel subunits (14 -17) , respectively. Editing of these viral and cellular RNAs results in codon changes and, thus, in mRNAs that encode protein products with altered functional activities (12, 17) . Furthermore, the A-to-I deaminations observed both in viral genomes and cellular pre-mRNA transcripts are dependent upon double-stranded regions within the substrate RNAs (17) (18) (19) .
Protein purification and molecular cloning studies established that the ADAR enzymes constitute a multi-gene family of enzymes (3) . So far cDNAs for functional deaminases encoded by two human ADAR genes, ADAR1 and ADAR2, have been characterized (17) . We isolated ADAR1 as an interferoninducible enzyme (20, 21) . ADAR1 possesses both dsRNA binding and Z-DNA binding activities (21) (22) (23) (24) (25) (26) (27) (28) (29) . ADAR1 is a 1226amino acid protein containing in the central region three functionally distinct copies of the highly conserved doublestranded RNA binding motif (dsRBM), designated as R I , R II , and R III ; these dsRBMs are implicated in the recognition of dsRNA structures within the substrate RNAs (21, 25, 30) . The prototype dsRBM, first described in the interferon-inducible RNA-dependent protein kinase PKR (31) , was subsequently identified in several proteins now known to be double-stranded RNA-binding proteins (31, 32) . The core amino acid residues of the dsRBM within PKR kinase, crucial for the dsRNA binding activity of PKR (33) (34) (35) (36) , are fully conserved in each of the three repeated dsRBM copies found in ADAR1 (21, 37) . More strikingly, characterization of ADAR1 and PKR genomic clones demonstrated that the codon phasing is precisely conserved at the junctions of the three exons which specify the three dsRBMs of ADAR1 and also at the junctions of the two exons that specify the two dsRBMs of PKR (38) . A repeated domain present in the N-terminal region of ADAR1 homologous to the N-terminal region of the vaccinia virus E3L protein (21) corresponds to two Z-DNA binding domains of ADAR1, designated Z␣ and Z␤ (27, 28) .
Two immunologically related forms of the human ADAR1 deaminase are present in a variety of human cell lines: an interferon-inducible ϳ150-kDa protein present in both the cytoplasm and nucleus and a constitutively expressed ϳ110-kDa truncated protein present predominantly, if not exclusively, in the nucleus (21) . The gene encoding these proteins maps to human chromosome 1q21. 1-21.2 (39) . Two promoters, one interferon-inducible and the other not, initiate transcription of the ADAR1 gene, and alternative splicing of unique exon 1 structures to a common exon 2 junction generates RNA transcripts with the deduced coding capacity for either the ϳ150-kDa protein or the ϳ110-kDa protein (40) . A second ADAR gene, ADAR2, encodes a ϳ80-kDa protein (41, 42) that maps to human chromosome 21q22.3 (43) . Unlike ADAR1, ADAR2 has a shorter N-terminal region and only two dsRNA-binding motifs encoded by one single large exon (41, 43) . The ADAR1 and ADAR2 dsRNA adenosine deaminases display differential editing activities for the editing sites within GluR-B RNA transcripts (16, 41, 42) .
Alternative splicing is an important strategy for generating multiple protein isoforms possessing different biological activities from a single genomic locus (44) . We have described three naturally occurring splice variant isoforms of human ADAR1 ( Fig. 1 ) that are differentially expressed in a tissue-specific fashion (38) . In comparison to the full-length 1226-amino acid ADAR1 protein (21, 25, 30) , designated ADAR1-a, the variant designated ADAR1-b is a 5Ј-splice site variant that contains a deletion of 26 amino acids between the R III dsRBM and the catalytic deaminase domain. The ADAR1-c variant has an additional deletion of 19 amino acids resulting from a 3Ј-splice site selection between the R II and R III dsRBMs. Although the three ADAR1 isoforms exhibit comparable deaminase activity when assessed with a synthetic dsRNA substrate, site-directed mutagenesis of individual dsRBMs revealed that the three dsRBM copies in ADAR1 variants are functionally distinct (38) . Similar to ADAR1, multiple splice variant isoforms of ADAR2 have also been identified, some of which show distinguishable deaminase activities (42) . In the case of ADAR2, the alternative splice site variants differ in the catalytic domain (42, 43, 45) , the N-terminal region (46) , and at the extreme C terminus (42) rather than in the RNA-binding region as seen for the ADAR1 variants (38) . It is now apparent that the RNA-specific adenosine deaminases constitute a family of enzymes specified by alternative splicing of transcripts from at least two genes.
Serotonin (5-hydroxytryptamine; 5-HT) is a biogenic amine that elicits a wide variety of physiological functions as a neurotransmitter, mediated by interaction with multiple distinct subtypes of cell surface receptors (47) . The rat serotonin-2C receptor (5-HT 2C R), one of the three 5-HT 2 subtype receptors linked to phospholipase C via G-protein coupling, is regulated by RNA editing (48) . The third exon of 5-HT 2C R includes the coding region for the second putative intracellular loop of the receptor (49) . Within the third exon of 5-HT 2C R, four A-to-I editing sites (denoted A, B, C, and D) have been identified that specify three amino acid substitutions (48) . The genomic sequence specifies amino acid residues Ile, Asn, and Ile in the three positions that are substituted with the residues Val, Ser, and Val that are encoded by the fully edited mRNA ( Fig. 2A ). This editing is dictated by a sequence within the adjacent intron 3 that possesses an imperfect inverted repeat, which forms a potential duplex structure with the 3Ј end of exon 3 where the sites of adenosine deamination are located (17) . Editing at all of the four sites results in a 10 -15-fold reduction in G-protein-mediated signaling as assessed by dose-response analysis of inositol phosphate accumulation with serotonergic agonists in transiently transfected NIH-3T3 cells (48) . Cotransfection experiments indicated that both ADAR1 and ADAR2 are involved in editing the 5-HT 2C R RNA (48) .
In this study, we describe the site-dependent in vitro editing of 5-HT 2C R transcripts by the splice variant isoforms of ADAR1 (38) . All three ADAR1 variants were significantly more effi-cient for editing the A than the B or C sites of 5-HT 2C R RNA in vitro, while none was capable of effectively modifying the D site. Mutational analysis of the three dsRBM motifs showed that the R I and R II motifs were relatively more important for the editing of the 5-HT 2C R RNA in vitro than for the deamination of a synthetic dsRNA substrate. Quantitative reverse transcription (RT)-PCR analyses of the RNA transcripts from dissected rat brain regions revealed the differential expression of the key RNA editing components, including ADAR1-a and -b, ADAR2, and the substrate 5-HT 2C R pre-mRNA. Higher levels of ADAR1-a transcripts were detected than ADAR1-b in all samples. However, among the brain regions examined, ADAR1-b transcripts were most abundant in choroid plexus, the same region where the 5-HT 2C R pre-mRNA substrate was also present at the greatest level.
EXPERIMENTAL PROCEDURES
Expression and Assay of Recombinant ADAR1 Proteins-Construction of ADAR1 expression vectors used the pcDNA I/Neo vector, in which ADAR1 translation initiates at Met-1 to give the full-length (FL) form or at Met-296 to give the N-terminally truncated (M296) form of the ADAR1 protein, as described previously (21, 38) . Wild-type FL and M296 constructs included the three naturally occurring splice site variants ADAR1-a, -b, and -c (38) . Mutant ADAR1-b constructs, both in the FL and M296 forms, in which the dsRBM containing an amino acid substitution at the critical lysine residue required for RNA-binding, have also been described (37, 38) . These substitution mutants include the three single mutants [R I (K554E), R II (K665E), or R III (K776E)], in which one of the three dsRBM copies was mutated (37) .
Monkey kidney COS-1 cells, maintained in monolayer culture using Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (HyClone), were employed for the expression of ADAR1 proteins. Transfections with wild-type or mutant ADAR1 cDNA expression vectors were carried out by the DEAE-dextran-chloroquine phosphate method (50) . Transfected cells were harvested and, to eliminate endogenous COS nuclear ADAR proteins, cytoplasmic fractions were prepared as a source of recombinant ADAR1 as described previously in detail (29, 38) . The expression of ADAR1 proteins in transfected cells was monitored by Western immunoblot analysis (21); antibody-antigen complexes were subsequently detected with 125 I-labeled protein A and autoradiography, followed by quantification using a molecular imager system (Bio-Rad GS-525). The dsRNA-specific adenosine deaminase activity of the expressed recombinant ADAR1 proteins was measured with a fully complementary 32 P-labeled synthetic dsRNA substrate as described previously (21, 29, 38) . One unit of the recombinant ADAR1 deaminase activity is defined as the amount required to catalyze 3% A-to-I conversion for the synthetic dsRNA substrate (21) in 2 h at 30°C in the standard assay. All wild-type ADAR1 splice variants possessed comparable specific deaminase activity on dsRNA substrate (38) . Inosine conversion from adenosine was analyzed by thin layer chromatography (TLC) on cellulose NM 300 glass plates (Macherey and Nagel) to separate IMP and AMP following hydrolysis of the deaminated RNA product with nuclease P1 (Amersham Pharmacia Biotech). Quantitation was carried out with molecular imager system.
5-HT 2C R RNA Editing
Assays-A 288-nt 5-HT 2C R RNA transcript spanning 178 nt of exon 3 and 110 nt of the proximal sequence of intron 3 has been shown to be editing-competent (48) . This RNA transcript was made by in vitro transcription and used as the substrate of editing assays. Briefly, XhoI-linearized plasmid DNA (5 g) with the 288-nt 5-HT 2C R minigene subcloned in pBKS II Ϫ was transcribed in vitro using phage T7 RNA polymerase (New England Biolabs) according to the manufacturer's instructions. The RNA transcript was recovered by precipitation with ethanol after extraction with phenol and chloroform. In a standard editing assay, the 5-HT 2C R RNA transcript was incubated at a final concentration of about 1 nM in a 100-l reaction mixture that contained recombinant ADAR1 protein from the cytoplasmic fraction of transfected COS cells. After incubation in the presence of 20 units of RNase inhibitor (Promega) for 4 h at 30°C, the edited RNA was recovered again and subjected to RT-PCR prior to quantification of editing by primer extension analysis.
RT-PCR-The 5-HT 2C R RNA transcripts edited in vitro by recombinant ADAR1 proteins and in vivo using total RNA isolated from dissected rat brain regions were subjected to RT-PCR with Taq DNA polymerase (Fisher) under conditions recommended by the manufacturer. Reverse transcription was performed at 42°C with the primer I3(Ϫ)288 (5Ј-GACAACCGATCAAACGCAATG-3Ј), which is specific for the pre-mRNA substrate, using avian myeloblastosis virus reverse transcriptase (Promega). The I3(Ϫ)288 primer corresponds to nt 175-195 of 5-HT 2C R intron 3, with the A site of editing designated as ϩ1 (48) . The RNA from dissected rat brain areas of 8 -12-week-old animals was as described previously (48) and included choroid plexus, cortex, hippocampus, olfactory bulb, and striatum. The brain-derived RNA samples were pretreated by RQ-1 DNase (Promega) and recovered by ethanol precipitation after extraction with phenol and chloroform before RT to remove any contaminating genomic DNA. Nested PCR subsequently amplified a 188-base pair product with primers E3(ϩ)6 (5Ј-GTGCCCCGTCTGGATTTCAC-3Ј) (nt 381-400) (M21410) (49) and I3(Ϫ)193 (5Ј-GCCAGGTATATTTACCTATTG-3Ј) (nt 80 -100 relative to the A site) (48) . To examine the editing of mature 5-HT 2C R mRNA from various brain regions, primers E3(ϩ)6 and E4(Ϫ)621 (5Ј-CGTGGTGT-TATTCACGAACAC-3Ј) (nt 601-621) (M21410) (49) were used to produce a 241-base pair product from randomly primed RT-cDNA (see below).
Reverse transcription was also carried out at 37°C with random hexamer oligonucleotides using Moloney murine leukemia virus reverse transcriptase (New England Biolabs) for the total RNA isolated from the dissected rat brain regions, and limiting amounts of the resultant cDNA were then subjected to quantitative RT-PCR analyses. In PCR reactions, at least one primer was end-labeled by T4 polynucleotide kinase (New England Biolabs) with [␥-32 P]ATP (Amersham Pharmacia Biotech). For quantitation of ADAR1 (U18121) (21) , primers (ϩ)1900 (5Ј-CACTGCTTGAGTGTATGC-3Ј) (nt 1900 -1917) and (Ϫ)2577 (5Ј-TCTGGTCATGGAAGGTGC-3Ј) (nt 2560 -2577) were used; for ADAR2 (U76421) (42) , primers (ϩ)857 (5Ј-CTCTGAGGCCCACCT-GGCC-3Ј) (nt 857-875), and (Ϫ)1410 (5Ј-CCAGGACCAGGCGT-GAGAC-3Ј) (nt 1392-1410) were used; and for 5-HT 2C R pre-mRNA, primers E(ϩ)6 and I3(Ϫ)193 were used with the RT-cDNA product generated using primer I3(Ϫ)288. As a standard control, ␣-tubulin was quantified using the primers ␣-T(ϩ)313 and ␣-T(Ϫ)STOP generously provided by Prof. S. Feinstein (University of California, Santa Barbara, CA). The symbol (ϩ) indicates the sense primer, and (Ϫ) the antisense primer.
Poisoned Primer Extension Analysis of 5-HT 2C R Editing-The RT-PCR products spanning the editing sites of 5-HT 2C R were purified from 1% agarose gel and subjected to primer extension analysis as shown in Fig. 2B . Two primers, (Ϫ)AB (5Ј-GGCTATGCTCAAYAGGAYTAC-3Ј) (nt 473-493, YϭC/T) for the A and B sites, and (ϩ)CD (5Ј-CCGGTAT-GTAGCARTRCG-3Ј) (nt 456 -473, R ϭ A/G) for the C and D sites, were 5Ј-end-labeled and annealed to denatured DNA templates. Three sets of poisoned extension reactions were established as indicated in Fig. 2B to measure the editing efficiency, using modified T7 DNA polymerase (Sequenase version 2.0) according to the manufacturer's instructions (U. S. Biochemical Corp.). Each set of reaction contained a combination of one dideoxynucleoside 5Ј-triphosphate (ddNTP) at 1 mM and the other three deoxynucleoside 5Ј-triphosphates (dNTPs) each at 0.1 mM. Extended products were resolved on denaturing 16% polyacrylamide gel with 7 M urea and quantified using a molecular imaging system. (38) . Furthermore, the specific enzyme activities of the M1 FL form and the M296 N-terminally truncated form of the three ADAR1 splice variants are all comparable when measured with fully complementary synthetic dsRNA (38) . RNA transcripts encoding the serotonin-2C receptor undergo RNA editing at four sites in which genomic DNAspecified adenosines are converted to inosines in the edited mRNA ( Fig. 2A ) by dsRNA-specific adenosine deaminases (48) . Little is known regarding the basis of the site-selectivity, and the enzymology, of the 5-HT 2C R editing process. Therefore, we examined the ability of the three ADAR1 splice variants to catalyze the site-specific editing of the 5-HT 2C R RNA substrate in vitro. A poisoned primer extension strategy was used as shown in Fig. 2B . Oligonucleotide primer (Ϫ)AB was used to measure editing at the A and B sites, either coupled or uncoupled; primer (ϩ)CD was used for the C and D sites.
RESULTS

Site
The three recombinant ADAR1 splice site variant proteins were all capable of modifying the 288-nt 5-HT 2C R RNA substrate in vitro in a site-selective fashion (Fig. 3A) . The ADAR1-a, -b, and -c variants all showed a preference for the A site of 5-HT 2C R RNA (Fig. 3B ). None of the three ADAR1 splice variants were able to effectively edit the D site ( Fig. 3B ). When the specific editing activity was obtained with 5-HT 2C R RNA as the substrate, quantification of the editing products revealed that all three ADAR1 splice variants (either in the FL or the M296 form) catalyzed editing at the A site much more efficiently than either the B or the C sites. The preference for the A site displayed by the FL ADAR1-a, -b, and -c enzymes was about 3-, 7-, and 10-fold over that for the B site, and about 9-, 7-, and 5-fold over that for the C site, respectively. For each of the three 5-HT 2C R adenosine sites that were deaminated by ADAR1, the three ADAR1 splice variants displayed modestly different editing activities (Fig. 3B ). For the A and C sites, the FL ADAR1-b and -c proteins showed consistently higher editing activity than ADAR1-a. By contrast, for the poorly edited B site, ADAR1-a was somewhat more active than either ADAR1-b or -c. Interestingly, of the RNA transcripts with A-to-I modification at the B site, about 40 -60% were uncoupled to the A site (Fig. 3A, middle) . As was observed with dsRNA as the substrate, the N-terminal region of ADAR1 that includes the Z-DNA binding Z␣ motif (21, 28) was not required for editing of the 5-HT 2C R RNA substrate. The editing activities of the truncated M296 ADAR1-a, -b, and -c proteins were compa-FIG. 1. Schematic structure of the three ADAR1 splice variants (a, b, and c) and mutant proteins used in the experiments described herein. The central region of ADAR1 includes three copies of the dsRBM, designated R I , R II , and R III. The position of the conserved lysine residue in each of the three dsRBMs that was mutated is indicated: in the R I mutant, K554E; in the R II mutant, K665E; and in the R III mutant, K776E. The translation initiation sites for the full-length (M1) and the N-truncated (M296) forms of the ADAR1-a, -b, and -c proteins are also indicated. rable to those displayed by the full-length ADAR1 proteins (Fig. 3B) .
Functionally Distinct RNA-binding Motifs of ADAR1 Associated with Editing of 5-HT 2C R RNA-Previous mutagenesis studies revealed that the three repeated copies of the dsRBM found in ADAR1 are functionally distinct from one another (37) , and that the functional importance of each individual dsRBM depends upon the ADAR1 splice variant when synthetic dsRNA is utilized as the substrate (38) . Using the recombinant ADAR1-b splice variant, we examined the effect of the equivalent substitution mutation introduced into each of the three dsRBMs of ADAR1 on editing activity measured with the natural 5-HT 2C R RNA substrate as compared with a fully complementary synthetic dsRNA substrate. For each of three dsRBM mutants, R I , R II , and R III , the highly conserved lysine residue within the dsRBM core that is essential for RNAbinding activity was mutated (37, 38) . In agreement with earlier observations obtained with a synthetic [ 32 P]dsRNA substrate, the R III copy of ADAR1 was the most important of the three dsRBMs and the R I and R II copies were less important for deaminase activity, either in the FL or the M296 form of the protein (Fig. 4A) . When the 288-nt 5-HT 2C R RNA was tested as the substrate, mutation in any one of the three dsRBMs of ADAR1 reduced editing at the A site ( Fig. 4B) . Comparison of the deaminase activities obtained with the wild-type and mutant ADAR1 proteins for editing of the A site of the 5-HT 2C R RNA with the activities seen for synthetic dsRNA revealed that the R I and R II copies of ADAR1-b were more important for 5-HT 2C R RNA editing than for deamination of synthetic dsRNA.
Expression Patterns of ADARs and 5-HT 2C R in Dissected Rat Brain Regions-To examine the expression patterns in the brain of the known gene products thought to be involved in the editing of 5-HT 2C R RNA editing, quantitative RT-PCR was carried out utilizing RNA isolated from five dissected rat brain regions. RNA from choroid plexus (CP), cortex (Co), hippocampus (Hi), olfactory bulb (OB), and striatum (St) was used to measure ADAR1, ADAR2, and 5-HT 2C R transcript levels. The PCR primers flanking the two splice site deletions of ADAR1 detected two products that corresponded to ADAR1-a and -b, respectively (Fig. 5A, upper) . Their identities as the a and b variants of ADAR1 were determined by gel mobility using the three human ADAR1 variants as reference markers (data not shown). The ADAR1-c variant was not detected in rat brain. The ADAR1-a transcript was more abundant than the ADAR1-b transcript in RNA isolated from all of the brain regions; the level of ADAR1-b relative to ADAR1-a was highest in choroid plexus as compared with the other regions ( Fig. 5 ). Like ADAR1, the ADAR2 transcript was also efficiently expressed in all five regions of the brain examined ( Fig. 5 ). Relative to ␣-tubulin as an internal standard, the lowest relative expression level of ADAR1 and ADAR2 transcripts was found in the cortex and the highest levels of both ADAR deaminase RNAs in the other four brain regions. The pre-mRNA encoding 5-HT 2C R, the substrate of ADARs, showed a prominent tissuespecific expression pattern, with the highest level observed in choroid plexus (Fig. 5) .
Editing Patterns of 5-HT 2C Receptor in the Brain-To assess whether the expression levels of the different forms of ADAR deaminase correlate with the degree of editing of the substrate 5-HT 2C R RNA, the percent adenosine modification at the A, B, C, and D sites was determined for the 5-HT 2C R RNA transcripts from different areas of rat brain. The RT-PCR products analyzed were derived from the 5-HT 2C R pre-mRNA, the actual target substrate of ADAR enzymes, using primers positioned within exon 3 and intron 3, and also from mature mRNA using primers within exon 3 and exon 4. Using the same primer extension strategy, the results obtained with the exon 3/intron 3 primer pair shown in Fig. 6 demonstrated that 5-HT 2C R RNA editing occurred efficiently in the brain prior to splicing of the RNA transcripts. These observations made with 5-HT 2C R pre-mRNA are similar to those obtained for mature mRNA encoding 5-HT 2C R (Ref. 48 ; data not shown). Relatively lower editing at the A and B sites was found in choroid plexus as compared with the four other regions of the brain examined, cortex, hippocampus, olfactory bulb, and striatum. However, RNA from all regions possessed comparable editing at the C and D sites. In contrast to editing observed in vitro (Fig. 3) , only about 10% of A-to-I modifications at the B site were uncoupled to the modification at the A site for the pre-mRNA substrate (Fig. 6 ) and even less (ϳ5%) was found with mature mRNA (data not shown).
DISCUSSION
Using individual recombinant ADAR1 proteins, we found that the ADAR1-a, -b, and -c splice site variants exhibited differential A-to-I editing activities for the four target sites within a 288-nt 5-HT 2C R substrate RNA. The three human ADAR1 variants all possessed editing activity for the A, B, and 
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C editing sites of 5-HT 2C R but were inactive for the D site ( Fig.  3 ). However, they showed substantially greater activity for the A site than for either the B or C site. These results indicate that the two deletions introduced by alternative splicing that alter the spacing between the RNA-binding motifs and the catalytic domain of ADAR1 do not significantly affect the site-selectivity for editing the 5-HT 2C R RNA substrate in vitro. However, for the A and C sites, ADAR1-b and -c possessed somewhat higher editing activity than did ADAR1-a; by contrast, ADAR1-a was more active than ADAR1-b and -c for the B site editing (Fig. 3) . The differential activities displayed by the ADAR1 splice site variants suggest that the two deletions in the spacer regions may indeed affect how efficiently an adenosine at a particular site of the substrate bound by the dsRBMs is presented to the catalytic center of ADAR1 for deamination.
Mutational analysis revealed that the functional importance of the repeated RNA-binding motifs R I , R II , and R III differed for the editing of the A site of 5-HT 2C R RNA as compared with the random deamination of a synthetic dsRNA substrate (Fig. 4) .
When the deaminase activities of wild-type and single amino acid substitution mutant ADAR1-b proteins were compared for A site editing and dsRNA deamination, the R I and R II dsRBM motifs were found to be more important with the 5-HT 2C R RNA substrate than a synthetic dsRNA substrate. The R III motif was of central importance for editing the A site of 5-HT 2C R RNA, consistent with earlier observations obtained with synthetic dsRNA (37) and GluR-B RNA (51) where a wild-type R III motif was found essential for efficient catalysis. However, the R I and R II dsRBM motifs were relatively less important for deamination of synthetic dsRNA (38) important for efficient A site editing of 5-HT 2C R RNA. These differences between 5-HT 2C R RNA and the GluR-B RNA and dsRNA substrates conceivably reflect sequence-dependent structural features of the serotonin receptor RNA required to confer binding with specificity for selective deamination of the A site. Surprisingly little is known about the molecular basis of protein-dsRNA interactions relative to our understanding of protein-DNA interactions. NMR and crystallography studies of the isolated dsRBM from Escherichia coli RNase III and Xenopus laevis RNA-binding proteins show an ␣-␤-␤-␤-␣ protein topology (32, 52) . The residues of the dsRBM involved in RNA binding cluster on one face of the motif and, with synthetic dsRNA, the Xenopus dsRBM interacts with two successive minor grooves and across the intervening major groove on one face of the RNA helix (52) . RNAs selected for binding to the dsRNA binding motifs of the PKR kinase often possess secondary structure defects consistent with a role of A-G mismatch and noncontiguous helixes in PKR dsRBM-RNA interactions (53) .
Quantitative RT-PCR analyses of brain RNA demonstrated significant expression, in all five of the rat brain regions examined, of the principal components known to be involved in the editing of 5-HT 2C R RNA. These included pre-mRNA encoding 5-HT 2C R, the bona fide substrate for deamination reaction, as well as ADAR1 and ADAR2, the two ADAR enzymes thought to mediate the editing reaction (48) . Two ADAR1 splice variants, ADAR1-a and -b, as well as ADAR2, were expressed in all brain regions, whereas the ADAR1-c variant was not detectable in any of the brain regions examined (Fig. 5A ). ADAR1-a was the major form of ADAR1 detected in all regions of the brain. Curiously, however, expression of ADAR1-b and the 5-HT 2C R showed a similar region-specific pattern. The greatest expression of ADAR1-b was observed in choroid plexus where the 5-HT 2C R pre-mRNA was also most abundant ( Fig. 5 substrate. Based upon the study of inosine-containing RNA transcripts, it has been estimated that one adenosine out of every ϳ17,000 nucleotides of mRNA in the brain undergoes A-to-I editing (55) . The expression of ADAR deaminases likely correlates with the total pool of RNA species to be edited, including the 5-HT 2C R pre-mRNA. The ADAR1-c splice variant, which was not detectable in rat brain tissues, has been detected only in human kidney (38) . This tissue-selective expression of ADAR1-c potentially reflects the presence of one or more RNA substrates whose expression also are tissue-dependent.
Examination of the editing status of the pre-mRNA encoding the serotonin-2C receptor revealed a similar region-specific pattern as that described for the mature 5-HT 2C R mRNA (48) . Editing at the A and B sites of 5-HT 2C R RNA was less efficient in choroid plexus as compared with cortex, hippocampus, olfactory bulb, and striatum, whereas editing at the C and D sites was generally comparable in all five of the brain regions ( Fig.  6 ). It is noteworthy that the expression level of ADAR1 was relatively high in choroid plexus even though editing of 5-HT 2C R RNA was lowest in choroid plexus relative to other regions. This may reflect differential compartmentalization of editing enzymes and their substrates, or the presence of regulatory factors in choroid plexus that down-regulate the editing of 5-HT 2C R RNA by ADAR1. Such putative regulatory factors might include regulatory RNAs (56) or proteins (57) .
The editing efficiency observed for the 5-HT 2C R pre-mRNA in vivo was surprisingly high, and close to that seen earlier for the mature mRNA (Ref. 48 ; data not shown). This suggests that the A-to-I editing process occurs at the pre-mRNA level prior to processing, and would not be inconsistent with a co-transcriptional process similar to that proposed to involve the Z-DNA binding property of ADAR1 (28) . Interestingly, the 5-HT 2C R pre-mRNA from all regions of the brain contained a higher percentage of RNA species edited at the A site but not at the B site than did the exon 3-exon 4 spliced mature mRNA. How-ever, the percentages of 5-HT 2C R RNA species edited at both the A and B sites (coupled AB) and at the C site were lower for pre-mRNA than for mature mRNA, whereas editing percentages at the D site were similar for both types of RNA. These results suggest that editing of the 5-HT 2C R RNA substrate may proceed sequentially from the A to the B site.
In contrast to the editing results obtained in vitro for ADAR1 splice variants, editing at the B site of 5-HT 2C R RNA in rat brain was more efficiently and predominantly coupled to the editing at the A site ( Figs. 3 and 6 ). This may result from unknown cis-acting sequence elements that are absent in the 288-nt 5-HT 2C R RNA mini-substrate used in vitro, or the presence in vivo of auxiliary proteins that mediate efficient editing at the B site subsequent to editing the A site. Possibly relevant also are the observations that both human and rat 5-HT 2C R RNA transcripts undergo an alternative splicing event in the third exon that lead to a 95-nt deletion spanning the four editing sites, generating a truncated isoform of the receptor (54, 58) . Whether this would in any way modulate the editing status of the receptor remains to be determined. FIG. 6 . Analysis of editing of 5-HT 2C receptor RNA in rat brain. A, autoradiogram showing the primer extension products obtained for the pre-mRNA encoding 5-HT 2C R present in RNA isolated from the five indicated rat brain regions. Lanes 1 and 6, choroid plexus (CP); lanes 2 and 7, cortex (Co); lanes 3 and 8, hippocampus (Hi); lanes 4 and 9, olfactory bulb (OB); lanes 5 and 10, striatum (St). The expected extension products are indicated for (Ϫ)AB primer with ddTTP-containing nt mixture and (ϩ)CD primer with ddGTP-containing nt mixture. B, comparison of the site-specific editing efficiency of 5-HT 2C R pre-mRNA in the five brain areas for sites A, B, coupled AB, C, and D. Error bars were obtained from two independent experiments.
